PROTHENA CORPORATION PUBLIC LIMITED COMPANY Restructuring Reserve, Settled without Cash
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) reported Restructuring Reserve, Settled without Cash of $1.42 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-03.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringReserveSettledWithoutCash2 · last filed 2020-03-03
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY restructuring reserve, settled without cash for the quarter ending 2018-09-30 was $948.00K.
- PROTHENA CORPORATION PUBLIC LIMITED COMPANY restructuring reserve, settled without cash for fiscal 2018 was $1.42M.
| Period end | Restructuring Reserve, Settled without Cash 3 month | Restructuring Reserve, Settled without Cash 12 month |
|---|---|---|
| 2018-12-31 | $1.42M 10-K · filed 2020-03-03 | |
| 2018-09-30 | $948.00K 10-Q · filed 2018-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |